<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>ç¾å›½åŒ»ç–—ä¿é™©å’ŒåŒ»ç–—è¡¥åŠ©æœåŠ¡ä¸­å¿ƒå°†å‘åŒ»ç”Ÿæ”¯ä»˜è´¹ç”¨ï¼Œè®©ä»–ä»¬ä½¿ç”¨äººå·¥æ™ºèƒ½ç³»ç»Ÿè¯Šæ–­ç³–å°¿ç—…æ‚£è€…çš„çœ¼éƒ¨ç–¾ç—…ï¼Œå¹¶é€šè¿‡è„‘éƒ¨æ‰«ææ£€æµ‹ä¸­é£</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">ç¾å›½åŒ»ç–—ä¿é™©å’ŒåŒ»ç–—è¡¥åŠ©æœåŠ¡ä¸­å¿ƒå°†å‘åŒ»ç”Ÿæ”¯ä»˜è´¹ç”¨ï¼Œè®©ä»–ä»¬ä½¿ç”¨äººå·¥æ™ºèƒ½ç³»ç»Ÿè¯Šæ–­ç³–å°¿ç—…æ‚£è€…çš„çœ¼éƒ¨ç–¾ç—…ï¼Œå¹¶é€šè¿‡è„‘éƒ¨æ‰«ææ£€æµ‹ä¸­é£</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-11-12 00:28:07</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/11/27012938120d67fa96a98c6e7c1aaeba.jpg"><img src="http://img2.diglog.com/img/2020/11/27012938120d67fa96a98c6e7c1aaeba.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Some artificial intelligence breakthroughs happen in computer science labs or  tense televised board games between a person and a machine. The latest advance in medical  AI has less glamorous origins: the depths of US government bureaucracy.</p><p>ä¸€äº›äººå·¥æ™ºèƒ½çš„çªç ´å‘ç”Ÿåœ¨è®¡ç®—æœºç§‘å­¦å®éªŒå®¤æˆ–ç´§å¼ çš„ç”µè§†è½¬æ’­çš„äººä¸æœºå™¨ä¹‹é—´çš„æ£‹ç›˜æ¸¸æˆä¸­ã€‚åŒ»å­¦äººå·¥æ™ºèƒ½é¢†åŸŸçš„æœ€æ–°è¿›å±•å¹¶ä¸é‚£ä¹ˆå…‰å½©ç…§äººï¼šç¾å›½æ”¿åºœçš„å®˜åƒšä½œé£æ ¹æ·±è’‚å›ºã€‚</p><p> The US Centers for Medicare &amp; Medicaid Services (CMS) recently said it would pay for use of two AI systems: one that can diagnose a complication of diabetes that causes blindness, and another that alerts a specialist when a brain scan suggests a patient has suffered a stroke. The decisions are notable for more than just Medicare and Medicaid patientsâ€”they could help drive much wider use of AI in health care.</p><p>ç¾å›½åŒ»ç–—ä¿é™©å’ŒåŒ»ç–—è¡¥åŠ©æœåŠ¡ä¸­å¿ƒ(CMS)æœ€è¿‘è¡¨ç¤ºï¼Œå®ƒå°†æ”¯ä»˜ä¸¤ä¸ªäººå·¥æ™ºèƒ½ç³»ç»Ÿçš„ä½¿ç”¨è´¹ï¼šä¸€ä¸ªå¯ä»¥è¯Šæ–­å¯¼è‡´å¤±æ˜çš„ç³–å°¿ç—…å¹¶å‘ç—‡ï¼Œå¦ä¸€ä¸ªåœ¨è„‘éƒ¨æ‰«ææ˜¾ç¤ºæ‚£è€…ä¸­é£æ—¶æé†’ä¸“å®¶ã€‚è¿™äº›å†³å®šå€¼å¾—æ³¨æ„çš„ä¸ä»…ä»…æ˜¯åŒ»ç–—ä¿é™©å’ŒåŒ»ç–—è¡¥åŠ©æ‚£è€…-å®ƒä»¬å¯èƒ½æœ‰åŠ©äºæ¨åŠ¨äººå·¥æ™ºèƒ½åœ¨åŒ»ç–—ä¿å¥ä¸­çš„æ›´å¹¿æ³›ä½¿ç”¨ã€‚</p><p> Both products are already  cleared by the Food and Drug Administration and are in use by some providers. But new devices and treatments generally arenâ€™t widely used until the US government authorizes payments for Medicare and Medicaid patients. Private insurers often take their cues on whether to cover a new invention from CMS, although they usually pay higher rates.</p><p>è¿™ä¸¤ç§äº§å“éƒ½å·²è·å¾—ç¾å›½é£Ÿå“å’Œè¯ç‰©ç®¡ç†å±€(Food And Drug Administration)çš„æ‰¹å‡†ï¼Œä¸€äº›ä¾›åº”å•†æ­£åœ¨ä½¿ç”¨è¿™ä¸¤ç§äº§å“ã€‚ä½†åœ¨ç¾å›½æ”¿åºœæ‰¹å‡†ä¸ºåŒ»ç–—ä¿é™©å’ŒåŒ»ç–—è¡¥åŠ©æ‚£è€…æ”¯ä»˜è´¹ç”¨ä¹‹å‰ï¼Œæ–°çš„è®¾å¤‡å’Œæ²»ç–—æ–¹æ³•é€šå¸¸ä¸ä¼šå¹¿æ³›ä½¿ç”¨ã€‚ç§è¥ä¿é™©å…¬å¸é€šå¸¸ä¼šè€ƒè™‘æ˜¯å¦æ‰¿ä¿CMSçš„ä¸€é¡¹æ–°å‘æ˜ï¼Œå°½ç®¡ä»–ä»¬é€šå¸¸æ”¯ä»˜æ›´é«˜çš„è´¹ç‡ã€‚</p><p>  Last month, CMS began paying for the use of AI software called ContaCT, from San Francisco startup Viz.ai, under a program that encourages adoption of new technologies. ContaCT is installed in a hospital emergency department to alert a neurosurgeon when algorithms see evidence on a CT scan that a patient has a blood clot in their brain. Speeding up stroke diagnosis and treatment, even by minutes, can dramatically reduce a personâ€™s disabilities and recovery time.</p><p>ä¸Šä¸ªæœˆï¼ŒCMSå¼€å§‹æ”¯ä»˜æ—§é‡‘å±±åˆåˆ›å…¬å¸Viz.aiæ¨å‡ºçš„åä¸ºContactçš„äººå·¥æ™ºèƒ½è½¯ä»¶çš„ä½¿ç”¨è´¹ï¼Œè¿™æ˜¯ä¸€é¡¹é¼“åŠ±é‡‡ç”¨æ–°æŠ€æœ¯çš„è®¡åˆ’ã€‚åœ¨åŒ»é™¢æ€¥è¯Šç§‘å®‰è£…äº†æ¥è§¦å™¨ï¼Œå½“ç®—æ³•åœ¨CTæ‰«æä¸Šçœ‹åˆ°ç—…äººå¤§è„‘ä¸­æœ‰è¡€å—çš„è¯æ®æ—¶ï¼Œå°±ä¼šæé†’ç¥ç»å¤–ç§‘åŒ»ç”Ÿã€‚åŠ å¿«ä¸­é£çš„è¯Šæ–­å’Œæ²»ç–—é€Ÿåº¦ï¼Œå³ä½¿æ˜¯å‡ åˆ†é’Ÿï¼Œä¹Ÿå¯ä»¥æ˜¾è‘—å‡å°‘ä¸€ä¸ªäººçš„æ®‹ç–¾å’Œåº·å¤æ—¶é—´ã€‚</p><p>  The agency has also said it will soon pay for software called IDx-DR, which analyzes photos of a personâ€™s retinas to diagnose diabetic retinopathy, a complication of diabetes that can cause blindness. CMS proposed in August to pay for the software, which was created by Digital Diagnostics of Oakdale, Iowa.</p><p>è¯¥æœºæ„è¿˜è¡¨ç¤ºï¼Œå®ƒå°†å¾ˆå¿«æ”¯ä»˜åä¸ºIDx-DRçš„è½¯ä»¶çš„è´¹ç”¨ï¼Œè¯¥è½¯ä»¶åˆ†æä¸€ä¸ªäººçš„è§†ç½‘è†œç…§ç‰‡ï¼Œä»¥è¯Šæ–­ç³–å°¿ç—…è§†ç½‘è†œç—…å˜ï¼Œè¿™æ˜¯ä¸€ç§å¯èƒ½å¯¼è‡´å¤±æ˜çš„ç³–å°¿ç—…å¹¶å‘ç—‡ã€‚CMSåœ¨8æœˆä»½æè®®æ”¯ä»˜è¯¥è½¯ä»¶çš„è´¹ç”¨ï¼Œè¯¥è½¯ä»¶ç”±çˆ±è·åå·å¥¥å…‹ä»£å°”çš„æ•°å­—è¯Šæ–­å…¬å¸(Digital Diagnostics)å¼€å‘ã€‚</p><p>  Viz and Digital Diagnostics both  received FDA approval in 2018, making them pioneers in convincing regulators that AI can improve health outcomes. IDx was the first AI product approved to diagnose disease, a clinical call previously made only by human physicians. Convincing CMS that taxpayer dollars should be spent on medical AI could be considered a similar milestone.</p><p>VIZå’ŒDigital Diagnosticsåœ¨2018å¹´éƒ½è·å¾—äº†FDAçš„æ‰¹å‡†ï¼Œä½¿å®ƒä»¬æˆä¸ºè¯´æœç›‘ç®¡æœºæ„äººå·¥æ™ºèƒ½å¯ä»¥æ”¹å–„å¥åº·ç»“æœçš„å…ˆé©±ã€‚IDXæ˜¯ç¬¬ä¸€ä¸ªè¢«æ‰¹å‡†ç”¨äºè¯Šæ–­ç–¾ç—…çš„äººå·¥æ™ºèƒ½äº§å“ï¼Œè¿™æ˜¯ä¸€ç§ä»¥å‰åªç”±äººç±»åŒ»ç”Ÿæ‰“å‡ºçš„ä¸´åºŠç”µè¯ã€‚è¯´æœCMSç›¸ä¿¡çº³ç¨äººçš„é’±åº”è¯¥èŠ±åœ¨åŒ»ç–—äººå·¥æ™ºèƒ½ä¸Šï¼Œå¯ä»¥è¢«è®¤ä¸ºæ˜¯ä¸€ä¸ªç±»ä¼¼çš„é‡Œç¨‹ç¢‘ã€‚</p><p>  â€œThis is very important for everyone in AI,â€ says ophthalmologist Michael Abramoff, the CEO of Digital Diagnostics. The proposal to pay for IDx would also cover other AI tools that diagnose diabetic retinopathy.</p><p>â€œè¿™å¯¹äººå·¥æ™ºèƒ½é¢†åŸŸçš„æ¯ä¸ªäººéƒ½éå¸¸é‡è¦ï¼Œâ€çœ¼ç§‘åŒ»ç”Ÿè¿ˆå…‹å°”Â·é˜¿å¸ƒæ‹‰è«å¤«(Michael Abramoff)è¯´ï¼Œä»–æ˜¯æ•°å­—è¯Šæ–­å…¬å¸(Digital Diagnostics)çš„é¦–å¸­æ‰§è¡Œå®˜ã€‚æ”¯ä»˜IDxè´¹ç”¨çš„ææ¡ˆè¿˜å°†æ¶µç›–å…¶ä»–è¯Šæ–­ç³–å°¿ç—…è§†ç½‘è†œç—…å˜çš„äººå·¥æ™ºèƒ½å·¥å…·ã€‚</p><p> Government willingness to pay for use of AI tools could be good news for other companies working on medical AI products. Analysts CB Insights reports that $4 billion was invested into AI health care startups in 2019, up from nearly $2.7 billion in the previous year.</p><p>å¯¹äºå…¶ä»–è‡´åŠ›äºåŒ»ç–—äººå·¥æ™ºèƒ½äº§å“çš„å…¬å¸æ¥è¯´ï¼Œæ”¿åºœæ„¿æ„ä¸ºäººå·¥æ™ºèƒ½å·¥å…·çš„ä½¿ç”¨ä»˜è´¹å¯èƒ½æ˜¯ä¸ªå¥½æ¶ˆæ¯ã€‚åˆ†æå¸ˆCB InsightsæŠ¥å‘Šç§°ï¼Œ2019å¹´å‘äººå·¥æ™ºèƒ½åŒ»ç–—åˆåˆ›ä¼ä¸šæŠ•èµ„çš„èµ„é‡‘ä¸º40äº¿ç¾å…ƒï¼Œé«˜äºå‰ä¸€å¹´çš„è¿‘27äº¿ç¾å…ƒã€‚</p><p> CMS valued the brain and eye scans very differentlyâ€”highlighting the complexity of US health care and a challenge for new AI technology. In each case the agency faced a question with philosophical dimensions: How do you value the work of a piece of software that by design performs a task typically done by a highly skilled human? It came up with two very different answers.</p><p>CMSå¯¹å¤§è„‘å’Œçœ¼ç›æ‰«æçš„é‡è§†æˆªç„¶ä¸åŒï¼Œçªæ˜¾äº†ç¾å›½åŒ»ç–—ä¿å¥çš„å¤æ‚æ€§ï¼Œä»¥åŠå¯¹æ–°çš„äººå·¥æ™ºèƒ½æŠ€æœ¯çš„æŒ‘æˆ˜ã€‚åœ¨æ¯ä¸€ä¸ªæ¡ˆä¾‹ä¸­ï¼Œè¯¥æœºæ„éƒ½é¢ä¸´ç€ä¸€ä¸ªå“²å­¦å±‚é¢çš„é—®é¢˜ï¼šä½ å¦‚ä½•è¯„ä»·ä¸€æ¬¾è½¯ä»¶çš„å·¥ä½œï¼Œè€Œè¿™æ¬¾è½¯ä»¶åœ¨è®¾è®¡ä¸Šæ‰§è¡Œçš„ä»»åŠ¡é€šå¸¸æ˜¯ç”±é«˜æŠ€èƒ½çš„äººæ¥å®Œæˆçš„ï¼Ÿå®ƒç»™å‡ºäº†ä¸¤ä¸ªæˆªç„¶ä¸åŒçš„ç­”æ¡ˆã€‚</p><p> In the case of Vizâ€™s ContaCT, CMS ruled that hospitals should be eligible for up to $1,040 for using the software for certain patients, citing evidence that it substantially improves stroke treatment. The agency pondered whether AI software that merely speeds work typically performed by humans was novel enough for a program reserved for new technologies, noting that â€œhuman intelligence and human processes are not FDA approved or cleared technologies.â€</p><p>åœ¨VIZçš„æ¥è§¦æ¡ˆä¾‹ä¸­ï¼ŒCMSè£å®šï¼ŒåŒ»é™¢ä¸ºæŸäº›æ‚£è€…ä½¿ç”¨è¯¥è½¯ä»¶åº”è¯¥æœ‰èµ„æ ¼è·å¾—æœ€é«˜1040ç¾å…ƒçš„èµ”å¿ï¼Œç†ç”±æ˜¯æœ‰è¯æ®è¡¨æ˜ï¼Œè¯¥è½¯ä»¶æå¤§åœ°æ”¹å–„äº†ä¸­é£çš„æ²»ç–—ã€‚è¯¥æœºæ„æ€è€ƒï¼Œä»…ä»…åŠ å¿«é€šå¸¸ç”±äººç±»å®Œæˆçš„å·¥ä½œçš„äººå·¥æ™ºèƒ½è½¯ä»¶ï¼Œå¯¹äºä¸€ä¸ªä¸“ä¸ºæ–°æŠ€æœ¯ä¿ç•™çš„é¡¹ç›®æ¥è¯´ï¼Œæ˜¯å¦è¶³å¤Ÿæ–°é¢–ï¼Œå¹¶æŒ‡å‡ºâ€œäººç±»æ™ºèƒ½å’Œäººç±»è¿‡ç¨‹ä¸æ˜¯FDAæ‰¹å‡†æˆ–æ‰¹å‡†çš„æŠ€æœ¯ã€‚â€</p><p> Chris Mansi, CEO and founder of Viz, says CMSâ€™ approval has already encouraged more hospitals to sign up for ContaCT. It was previously used in about 500 major hospitals, who went ahead without the promise of government reimbursement because identifying stroke patients faster can increase the number of lucrative, time-sensitive surgeries they perform. â€œThe people benefiting were major hubs,â€ Mansi says. â€œMore hospitals can now use the software and get paid for it.â€</p><p>Vizçš„é¦–å¸­æ‰§è¡Œå®˜å…¼åˆ›å§‹äººå…‹é‡Œæ–¯Â·æ›¼è¥¿(Chris Mansi)è¡¨ç¤ºï¼ŒCMSçš„æ‰¹å‡†å·²ç»é¼“åŠ±äº†æ›´å¤šçš„åŒ»é™¢ç­¾çº¦è”ç³»ã€‚å®ƒä¹‹å‰åœ¨å¤§çº¦500å®¶å¤§åŒ»é™¢ä½¿ç”¨ï¼Œè¿™äº›åŒ»é™¢åœ¨æ²¡æœ‰æ”¿åºœæŠ¥é”€æ‰¿è¯ºçš„æƒ…å†µä¸‹ç»§ç»­è¿›è¡Œï¼Œå› ä¸ºæ›´å¿«åœ°è¯†åˆ«ä¸­é£æ‚£è€…å¯ä»¥å¢åŠ ä»–ä»¬è¿›è¡Œçš„æœ‰åˆ©å¯å›¾ã€æ—¶é—´æ•æ„Ÿçš„æ‰‹æœ¯çš„æ•°é‡ã€‚â€œå—ç›Šçš„äººæ˜¯ä¸»è¦çš„æ¢çº½ï¼Œâ€æ›¼è¥¿è¯´ã€‚â€œç°åœ¨æ›´å¤šçš„åŒ»é™¢å¯ä»¥ä½¿ç”¨è¿™æ¬¾è½¯ä»¶ï¼Œå¹¶ä¸ºæ­¤ä»˜è´¹ã€‚â€</p><p>  CMS has proposed that hospitals get paid much less for retina-checking software like IDx. Abramoff says it would be generally less than $20, though the amount varies depending on geography and other factors.</p><p>CMSå»ºè®®åŒ»é™¢ä¸ºåƒIDxè¿™æ ·çš„è§†ç½‘è†œæ£€æŸ¥è½¯ä»¶æ”¯ä»˜æ›´å°‘çš„è´¹ç”¨ã€‚é˜¿å¸ƒæ‹‰è«å¤«è¯´ï¼Œè¿™é€šå¸¸ä¸åˆ°20ç¾å…ƒï¼Œä½†å…·ä½“é‡‘é¢ä¼šå› åœ°ç†å’Œå…¶ä»–å› ç´ è€Œå¼‚ã€‚</p><p>  Gregory Nicola, chair of the American College of Radiology commission on economics, says the retina-scan payment will probably be more typical of how early AI imaging apps are valued. The new technology program Viz qualified for is tilted to be more generous, but it lasts only three years. Payments are reevaluated after the first year, and generally lowered. Apps that detect traces of a disease in an image are useful, but they donâ€™t dramatically change the human-dominated work of treating a patient, Nicola says. â€œThe AI weâ€™re seeing coming onto the market is very narrowly focused,â€ he says.</p><p>ç¾å›½æ”¾å°„å­¦ä¼š(American College Of Radiology)ç»æµå­¦å§”å‘˜ä¼šä¸»å¸­æ ¼é›·æˆˆé‡ŒÂ·å°¼å¤æ‹‰(Gregory Nicola)è¡¨ç¤ºï¼Œè§†ç½‘è†œæ‰«ææ”¯ä»˜å¯èƒ½æ›´èƒ½ä»£è¡¨æ—©æœŸäººå·¥æ™ºèƒ½æˆåƒåº”ç”¨çš„ä¼°å€¼ã€‚Vizæœ‰èµ„æ ¼å‚åŠ çš„æ–°æŠ€æœ¯é¡¹ç›®å€¾å‘äºæ›´åŠ æ…·æ…¨ï¼Œä½†å®ƒåªæŒç»­äº†ä¸‰å¹´ã€‚ä»˜æ¬¾åœ¨ç¬¬ä¸€å¹´åé‡æ–°è¯„ä¼°ï¼Œé€šå¸¸ä¼šé™ä½ã€‚å°¼å¤æ‹‰è¯´ï¼Œåœ¨å›¾åƒä¸­æ£€æµ‹ç–¾ç—…ç—•è¿¹çš„åº”ç”¨ç¨‹åºæ˜¯æœ‰ç”¨çš„ï¼Œä½†å®ƒä»¬ä¸ä¼šæ˜¾è‘—æ”¹å˜äººç±»ä¸»å¯¼çš„æ²»ç–—ç—…äººçš„å·¥ä½œã€‚â€œæˆ‘ä»¬çœ‹åˆ°è¿›å…¥å¸‚åœºçš„äººå·¥æ™ºèƒ½æ˜¯éå¸¸ç‹­éš˜çš„ï¼Œâ€ä»–è¯´ã€‚</p><p>  Abramoff and some others, including the American Academy of Ophthalmology and competing startup AEYE Health, have asked CMS to boost the payment for AI retinopathy diagnosis. They argue that providers need to get paid more for using IDx for it to be economically attractive. The Connected Health Initiative, an industry group, suggested the payment be set at $55. CMS said it does not comment on pending rules.</p><p>é˜¿å¸ƒæ‹‰è«å¤«å’Œå…¶ä»–ä¸€äº›äººï¼ŒåŒ…æ‹¬ç¾å›½çœ¼ç§‘å­¦ä¼šå’Œç«äº‰å¯¹æ‰‹AEYE Healthï¼Œå·²ç»è¦æ±‚CMSæé«˜äººå·¥æ™ºèƒ½è§†ç½‘è†œç—…å˜è¯Šæ–­çš„è´¹ç”¨ã€‚ä»–ä»¬è®¤ä¸ºï¼Œæä¾›å•†éœ€è¦ä¸ºä½¿ç”¨IDxè·å¾—æ›´å¤šæŠ¥é…¬ï¼Œæ‰èƒ½ä½¿å…¶åœ¨ç»æµä¸Šå…·æœ‰å¸å¼•åŠ›ã€‚è¡Œä¸šç»„ç»‡äº’è”å¥åº·å€¡è®®(Connected Health Initiative)å»ºè®®å°†æ”¯ä»˜é‡‘é¢å®šä¸º55ç¾å…ƒã€‚CMSè¡¨ç¤ºï¼Œå®ƒä¸ä¼šå¯¹æ‚¬è€Œæœªå†³çš„è§„åˆ™å‘è¡¨è¯„è®ºã€‚</p><p> Ravi Parikh, a retina specialist in Manhattan who is on the faculty at NYU Langone Health, coauthored a paper  published in July estimating that clinics wouldnâ€™t find IDx financially viable if CMS reimbursed at rates similar to those it has proposed.</p><p>çº½çº¦å¤§å­¦æœ—æ ¼å°¼å¥åº·å­¦é™¢(NYU Langone Health)çš„è§†ç½‘è†œä¸“å®¶æ‹‰ç»´Â·å¸•é‡Œå…‹(Ravi Parikh)æ˜¯çº½çº¦å¤§å­¦æœ—æ ¼å°¼å¥åº·å­¦é™¢(NYU Langone Health)çš„ä¸€åæ•™èŒå‘˜å·¥ï¼Œä»–åœ¨7æœˆä»½å‘è¡¨çš„ä¸€ç¯‡è®ºæ–‡ä¸­ä¼°è®¡ï¼Œå¦‚æœCMSçš„æŠ¥é”€è´¹ç‡ä¸å…¶æè®®çš„ç›¸ä¼¼ï¼Œè¯Šæ‰€å°†æ— æ³•å‘ç°IDXåœ¨è´¢åŠ¡ä¸Šå¯è¡Œã€‚</p><p> He says the agency could help both diabetes patients and the prospects for AI in health care by paying more. â€œThis has to be incentivized to push adoption,â€ he says.</p><p>ä»–è¯´ï¼Œè¯¥æœºæ„å¯ä»¥é€šè¿‡æ”¯ä»˜æ›´å¤šè´¹ç”¨æ¥å¸®åŠ©ç³–å°¿ç—…æ‚£è€…å’ŒåŒ»ç–—ä¿å¥é¢†åŸŸçš„äººå·¥æ™ºèƒ½å‰æ™¯ã€‚ä»–è¯´ï¼šâ€œè¿™å¿…é¡»å—åˆ°æ¿€åŠ±ï¼Œæ‰èƒ½æ¨åŠ¨é¢†å…»ã€‚â€</p><p> Ashok Subramanian, CEO of CareportMD, is among those using IDx with patients. His company has five of the machines installed in clinics inside Albertsons stores in Delaware and Pennsylvania, and also rotates them to other clinics for diabetes screening days. He has billed insurers for the AI eye checks using codes that cover conventional retina photos read by a doctor. That works out economically as part of an appointment with a package of tests, he says. But it wonâ€™t make financial sense simply to screen patients unless the payments are increased, he says. â€œDiabetes is an epidemic, and diabetic retinopathy is a leading cause of blindness,â€ he says. â€œHopefully, new reimbursement models will enable this technology to propagate much faster.â€</p><p>CareportMDçš„é¦–å¸­æ‰§è¡Œå®˜é˜¿è‚–å…‹Â·è¨å¸ƒæ‹‰æ›¼å°¼äºš(Ashok Subramanian)æ˜¯å¯¹æ‚£è€…ä½¿ç”¨IDxçš„äººä¹‹ä¸€ã€‚ä»–çš„å…¬å¸åœ¨ç‰¹æ‹‰åå·å’Œå®¾å¤•æ³•å°¼äºšå·çš„è‰¾ä¼¯æ£®é—¨åº—å†…çš„è¯Šæ‰€å®‰è£…äº†äº”å°è¿™ç§æœºå™¨ï¼Œå¹¶åœ¨ç³–å°¿ç—…ç­›æŸ¥æ—¥å°†å®ƒä»¬è½®æ¢åˆ°å…¶ä»–è¯Šæ‰€ã€‚ä»–å·²ç»å‘ä¿é™©å…¬å¸æ”¶å–äº†äººå·¥æ™ºèƒ½çœ¼ç§‘æ£€æŸ¥çš„è´¹ç”¨ï¼Œè¿™äº›æ£€æŸ¥ä½¿ç”¨çš„ä»£ç æ¶µç›–äº†åŒ»ç”Ÿè¯»å–çš„ä¼ ç»Ÿè§†ç½‘è†œç…§ç‰‡ã€‚è¿™åœ¨ç»æµä¸Šæ˜¯å¯è¡Œçš„ï¼Œå› ä¸ºè¿™æ˜¯é¢„çº¦ä¸€æ½å­æµ‹è¯•çš„ä¸€éƒ¨åˆ†ï¼Œä»–è¯´ã€‚ä½†ä»–è¯´ï¼Œé™¤éå¢åŠ æ”¯ä»˜ï¼Œå¦åˆ™ç®€å•åœ°å¯¹æ‚£è€…è¿›è¡Œç­›æŸ¥åœ¨ç»æµä¸Šæ˜¯æ²¡æœ‰æ„ä¹‰çš„ã€‚ä»–è¯´ï¼šâ€œç³–å°¿ç—…æ˜¯ä¸€ç§æµè¡Œç—…ï¼Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜æ˜¯å¯¼è‡´å¤±æ˜çš„ä¸»è¦åŸå› ã€‚â€â€œå¸Œæœ›æ–°çš„æŠ¥é”€æ¨¡å¼èƒ½è®©è¿™é¡¹æŠ€æœ¯æ›´å¿«åœ°ä¼ æ’­å¼€æ¥ã€‚â€</p><p>   ğŸƒğŸ½â€â™€ï¸ Want the best tools to get healthy? Check out our Gear teamâ€™s picks for the  best fitness trackers,  running gear (including  shoes and  socks), and  best headphones</p><p>ğŸƒğŸ½â€â™€ï¸æƒ³è¦æœ€å¥½çš„å¥åº·å·¥å…·å—ï¼Ÿçœ‹çœ‹æˆ‘ä»¬Gearå›¢é˜ŸæŒ‘é€‰çš„æœ€å¥½çš„å¥èº«è·Ÿè¸ªå™¨ã€è·‘æ­¥è£…å¤‡(åŒ…æ‹¬é‹å­å’Œè¢œå­)å’Œæœ€å¥½çš„è€³æœº</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.wired.com/story/us-government-pay-doctors-use-ai-algorithms">https://www.wired.com/story/us-government-pay-doctors-use-ai-algorithms</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/äººå·¥æ™ºèƒ½/">#äººå·¥æ™ºèƒ½</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/ç¾å›½/">#ç¾å›½</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/åŒ»ç–—ä¿é™©/">#åŒ»ç–—ä¿é™©</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/brain/">#brain</a></button></div></div><div class="shadow p-3 mb-5 bg-white rounded clearfix"><div class="container"><div class="row"><div class="col-sm"><div><a target="_blank" href="/story/1034542.html"><img src="http://img2.diglog.com/img/2020/11/thumb_8159550900a5e987bf71a82e96927802.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1034542.html">æ•™çš‡æ–¹æµå„æ•¦ä¿ƒè¿½éšè€…ç¥ˆç¥·äººå·¥æ™ºèƒ½å’Œæœºå™¨äººâ€œæ°¸è¿œä¸ºäººç±»æœåŠ¡â€</a></div><span class="my_story_list_date">2020-11-11 23:5</span></div><div class="col-sm"><div><a target="_blank" href="/story/1034499.html"><img src="http://img2.diglog.com/img/2020/11/thumb_629afb6fc44ff9c4bc4d14ddb571c607.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1034499.html">
äººå·¥æ™ºèƒ½ç»ˆç«¯å®‰å…¨å…¬å¸SentinelOneç¡®è®¤èèµ„2.67äº¿ç¾å…ƒï¼Œä¼°å€¼31äº¿ç¾å…ƒ</a></div><span class="my_story_list_date">2020-11-11 17:30</span></div><div class="col-sm"><div><a target="_blank" href="/story/1034461.html"><img src="http://img2.diglog.com/img/2020/11/thumb_7e3abe61c819a969dfcdc0d97a1fdfc9.jpeg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1034461.html">äººå·¥æ™ºèƒ½æ˜¾ç¤ºå‡ºè¡¡é‡é€‰æ°‘æƒ…ç»ªçš„æ½œåŠ›</a></div><span class="my_story_list_date">2020-11-11 11:39</span></div><div class="col-sm"><div><a target="_blank" href="/story/1034457.html"><img src="http://img2.diglog.com/img/2020/11/thumb_89aa5123dd24570a98eb612a51aeae71.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1034457.html">äººå·¥æ™ºèƒ½å¯èƒ½æ­£åœ¨è®©äººä»¬ä¹°ä¸œè¥¿</a></div><span class="my_story_list_date">2020-11-11 10:54</span></div></div></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è®¾è®¡/">#è®¾è®¡</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/æ¸¸æˆ/">#æ¸¸æˆ</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/åˆ›æ„/">#åˆ›æ„</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è‹¹æœ/">#è‹¹æœ</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/æ‘„å½±/">#æ‘„å½±</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è½¯ä»¶/">#è½¯ä»¶</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/ç¾å›½/">#ç¾å›½</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/å›¾ç‰‡/">#å›¾ç‰‡</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/æ‰‹æœº/">#æ‰‹æœº</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è§†é¢‘/">#è§†é¢‘</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/å¹¿å‘Š/">#å¹¿å‘Š</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/å…è´¹/">#å…è´¹</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è°·æ­Œ/">#è°·æ­Œ</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/ç½‘ç«™/">#ç½‘ç«™</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/å¾®è½¯/">#å¾®è½¯</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/ä¸‹è½½/">#ä¸‹è½½</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/éŸ³ä¹/">#éŸ³ä¹</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/linux/">#linux</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/åšå®¢/">#åšå®¢</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/ç¨‹åº/">#ç¨‹åº</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/è‰ºæœ¯/">#è‰ºæœ¯</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>